Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Camici

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Circulation|January 26, 2008
A change of scene: Paolo Camici, MD, FRCP, FESC. Interview by Emma WilkinsonPaolo Camici
International Journal of Cardiology|March 7, 2018
Transforming care for rare and inherited cardiovascular diseases through education and trainingPerry M Elliott, Paolo Camici
Heart, Lung & Circulation|January 3, 2009
Advances in coronary microvascular dysfunctionJohn F Beltrame, Filippo Crea, Paolo Camici
European Heart Journal|March 25, 2004
The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular functionMichael Pitt, David Dutka, Domenico Pagano, et al.
Journal of Cardiovascular Translational Research|August 10, 2013
Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodelingAida Moreno-Moral, Massimiliano Mancini, Giulia D'Amati, et al.
Heart (British Cardiac Society)|June 2, 2011
Right ventricular remodelling in systemic hypertension: a cardiac MRI studyGiancarlo Todiere, Danilo Neglia, Sergio Ghione, et al.
The American Journal of Cardiology|July 23, 2013
Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathyRossella D'Amato, Benedetta Tomberli, Gabriele Castelli, et al.
Clinical and Translational Medicine|July 29, 2021
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic CardiomyopathyMaria Lombardi, Davide Lazzeroni, Giulia Benedetti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2016
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of CardiologyFrancesco Barillà, Francesco Pelliccia, Mauro Borzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort studyCaterina Conte, Antonio Esposito, Rebecca De Lorenzo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Circulation|January 26, 2008
A change of scene: Paolo Camici, MD, FRCP, FESC. Interview by Emma WilkinsonPaolo Camici
International Journal of Cardiology|March 7, 2018
Transforming care for rare and inherited cardiovascular diseases through education and trainingPerry M Elliott, Paolo Camici
Heart, Lung & Circulation|January 3, 2009
Advances in coronary microvascular dysfunctionJohn F Beltrame, Filippo Crea, Paolo Camici
European Heart Journal|March 25, 2004
The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular functionMichael Pitt, David Dutka, Domenico Pagano, et al.
Journal of Cardiovascular Translational Research|August 10, 2013
Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodelingAida Moreno-Moral, Massimiliano Mancini, Giulia D'Amati, et al.
Heart (British Cardiac Society)|June 2, 2011
Right ventricular remodelling in systemic hypertension: a cardiac MRI studyGiancarlo Todiere, Danilo Neglia, Sergio Ghione, et al.
The American Journal of Cardiology|July 23, 2013
Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathyRossella D'Amato, Benedetta Tomberli, Gabriele Castelli, et al.
Clinical and Translational Medicine|July 29, 2021
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic CardiomyopathyMaria Lombardi, Davide Lazzeroni, Giulia Benedetti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2016
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of CardiologyFrancesco Barillà, Francesco Pelliccia, Mauro Borzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort studyCaterina Conte, Antonio Esposito, Rebecca De Lorenzo, et al.
Pageof 2